Vassiliki Economides
Direttore Finanziario/CFO presso GRITSTONE BIO, INC.
Patrimonio netto: 203 126 $ in data 31/05/2024
Posizioni attive di Vassiliki Economides
Società | Posizione | Inizio | Fine |
---|---|---|---|
GRITSTONE BIO, INC. | Direttore Finanziario/CFO | 23/06/2021 | - |
Altum Pharmaceuticals, Inc.
Altum Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Altum Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the clinical and commercial development of novel healthcare products for the treatment of women's gynecological neoplasia, autoimmune disorders, Hypercalcemia of Malignancy, Skeletal Related Events and Osteoporosis diseases. The company was founded in 2016 and is headquartered in Vancouver, Canada. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Vassiliki Economides
Precedenti posizioni note di Vassiliki Economides
Società | Posizione | Inizio | Fine |
---|---|---|---|
AURINIA PHARMACEUTICALS INC. | Contatto Relazioni con gli Investitori | 11/07/2016 | 01/03/2019 |
Public Communications Contact | 11/07/2016 | 01/03/2019 | |
Corporate Officer/Principal | 11/07/2016 | 01/03/2019 | |
BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 01/03/2015 | 01/06/2016 |
KEZAR LIFE SCIENCES, INC. | Contatto Relazioni con gli Investitori | 04/03/2019 | - |
Public Communications Contact | 04/03/2019 | - | |
PROSENSA HOLDING NV | Contatto Relazioni con gli Investitori | - | - |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Contatto Relazioni con gli Investitori | - | - |
Corporate Officer/Principal | - | - |
Formazione di Vassiliki Economides
The Trustees of Columbia University in The City of New York | Graduate Degree |
McGill University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Canada | 4 |
Paesi Bassi | 2 |
Posizioni
Investor Relations Contact | 4 |
Corporate Officer/Principal | 3 |
Public Communications Contact | 2 |
Settori
Health Technology | 7 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 4 |
---|---|
BIOMARIN PHARMACEUTICAL INC. | Health Technology |
AURINIA PHARMACEUTICALS INC. | Health Technology |
KEZAR LIFE SCIENCES, INC. | Health Technology |
GRITSTONE BIO, INC. | Health Technology |
Aziende private | 3 |
---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Prosensa Holding NV
Prosensa Holding NV BiotechnologyHealth Technology Prosensa Holding NV engages in the development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The company focuses on rare neuromuscular and neurodegenerative disorders, Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease. It has developed a portfolio of clinical and pre-clinical RNA-based drug candidates. Prosensa's current clinical portfolio is focused on the treatment of Duchenne Muscular Dystrophy. The company was founded in 2002 and is headquartered in Leiden, the Netherlands. | Health Technology |
Altum Pharmaceuticals, Inc.
Altum Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Altum Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the clinical and commercial development of novel healthcare products for the treatment of women's gynecological neoplasia, autoimmune disorders, Hypercalcemia of Malignancy, Skeletal Related Events and Osteoporosis diseases. The company was founded in 2016 and is headquartered in Vancouver, Canada. | Health Technology |
- Borsa valori
- Insiders
- Vassiliki Economides
- Esperienza